Key result
Bioprosthetic valves show ~4 mmHg lower 1-year mean gradients and less bleeding vs. mechanical valves.
Why the study?
The choice between bioprosthetic and mechanical prostheses for surgical valve replacement remains individualized, guided by patient age, bleeding risk, reproductive plans, and durability requirements.
How do bioprosthetic heart valves compare to mechanical heart valves regarding long-term clinical outcomes, reoperation, bleeding complications, and 1-year postoperative echocardiographic parameters across different age groups in patients undergoing surgical valve replacement?
Cohort (n=35)
No
How do bioprosthetic heart valves compare to mechanical heart valves regarding long-term clinical outcomes, reoperation, bleeding complications, and 1-year postoperative echocardiographic parameters across different age groups in patients undergoing surgical valve replacement?
Answers are grounded in this paper and cite their sources.
This single-center retrospective cohort supports guideline-concordant, individualized heart valve prosthesis selection, showing superior durability with mechanical valves in patients under 60 and lower bleeding risk and favorable hemodynamic profiles with bioprosthetic valves in older patients and pregnant women.
Background: The choice between bioprosthetic and mechanical prostheses for surgical valve replacement remains individualized, guided by patient age, bleeding risk, reproductive plans, and durability requirements. Methods: We retrospectively analyzed 35 patients (14 women, 21 men, including two pregnant women) who underwent valve replacement at a single tertiary referral centre in Mumbai, India, followed for up to 10 years, stratified into three age groups (<60, 60–70, and >70 years). Postoperative transthoracic echocardiographic parameters — mean transvalvular gradient, valve function, left ventricular (LV) dimensions, ejection fraction (EF), and peak jet velocity — were assessed at discharge, 6 months, and 1 year, and interpreted against current American Heart Association/American College of Cardiology (AHA/ACC) guidance. Results: Mechanical valves demonstrated superior durability with lower reoperation rates in patients under 60 years but carried a higher burden of anticoagulation-related bleeding. Bioprosthetic valves were associated with fewer bleeding complications and were preferred in patients over 70 years and in women of childbearing age; both pregnant patients who received bioprosthetic valves had uneventful pregnancies and deliveries. Conclusions: Prosthesis selection should remain an individualized, shared decision incorporating age, bleeding risk, reproductive status, and the patient's values, consistent with current international guidance.
No takes yet. Share an insight, caveat, or question.
1* et al. (2026) conducted a cohort in Valvular heart disease requiring surgical valve replacement (n=35). Bioprosthetic heart valve replacement vs. Mechanical heart valve replacement was evaluated on 1-year postoperative mean transvalvular gradient (mmHg). Bioprosthetic heart valves achieved lower 1-year mean transvalvular gradients and fewer bleeding events than mechanical valves, though mechanical valves showed superior durability in patients <60 years.
Synapse has enriched 10 related papers. Consider them for comparative context: